Table 7.
Percentage of completed and uncompleted vaccination schedules in 2015–2016 vs. 2017–2018 depending on the vaccine used.
| Vaccine | 2015 and 2016 Age Group N (%) | 2017 and 2018 Age Group N (%) | p | ||
|---|---|---|---|---|---|
| Schedule Completed | Schedule Not Completed | Schedule Completed | Schedule Not Completed | ||
| PCV10 1 | 126 (83.4) | 25 (16.6) | 574 (88.3) | 76 (11.7) | 0 = 0.105 |
| PCV13 2 | 330 (83.8) | 64 (16.2) | 138 (85.2) | 24 (14.8) | 0 = 0.675 |
1 PCV10—10-valent conjugate pneumococcal vaccine; 2 PCV13—13-valent conjugate pneumococcal vaccine.